Skeletal muscle metabolism in Duchenne muscular dystrophy (DMD): An in-vitro proton NMR spectroscopy study

Magnetic Resonance Imaging

Volumn 21, Issue 2, 2003, Pages 145-153

  Sharma, Uma ^a   Atri, Surinder ^a   Sharma, M C ^a   Sarkar, Chitra ^a   Jagannathan, N R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

DMD; In vitro; Metabolism; Muscle; Proton MR spectroscopy

Indexed keywords

2 OXOGLUTARIC ACID; ACETIC ACID; ALANINE; AMINO ACID; CARNITINE; CHOLINE; CREATINE; FATTY ACID; GLUCOSE; GLUTAMINE; GLYCEROPHOSPHORYLCHOLINE; LACTIC ACID; PERCHLORIC ACID; PHOSPHORYLCHOLINE;

AEROBIC METABOLISM; ANAEROBIC GLYCOLYSIS; ARTICLE; CHILD; CITRIC ACID CYCLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ENERGY METABOLISM; FATTY ACID TRANSPORT; GLUCONEOGENESIS; GLYCOLYSIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; METABOLITE; MUSCLE METABOLISM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SKELETAL MUSCLE; TISSUE LEVEL;

ADOLESCENT; ADULT; CARNITINE; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOHISTOCHEMISTRY; ISOLEUCINE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; VALINE;

EID: 0037308247     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(02)00646-X     Document Type: Article

References (63)

1. Arahata K, Ishiura S, Ishiguro T, Suhara Y, Eguchi C, Ishihara T, Nonaka I, Ogawa E, Sugita H. Immuno staining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy at the muscle cell membrane. Nature 1988;333:861-3.
2. Hoffman EP, Brown RL Jr, Kunkel LM. Dystrophin the protein product of Ducheene muscular dystrophy locus. Cell 1987;51:919-28.
3. Ervasti JM, Campbell KP. Membrane organization of the dystrophinglycoprotein complex. Cell 1991;66:1121-31.
4. Ervasti JM, Kahl SD, Campbell KP. Purification of dystrophin from skeletal muscle. J Biol Chem 1991;266:9161-5.
5. Matsumura K, Campbell KP. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle and Nerve 1994;17:2-15.
6. Fong P, Turner PR, Denetclaw WF, Steinhardt RA. Increased activity of calcium channels in myotubes of Duchenne human and mdx mouse origin. Science 1990;250:673-6.
7. Franco A, Lansman JB. Calcium entry through stretch inactivated ion channels in mdx myotubes. Nature 1990;344:670-3.
8. 31P MRS) in neuromuscular disorders. Ann Neurol 1991;30:90-7.
9. Argov Z, Lofberg M, Arnold DL. Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy. Muscle and Nerve 2000;23:1316-34.
10. Arnold DL, Taylor DJ, Radda GK. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol 1985;18:189-96.
11. Argov Z, Bank WJ, Moris J, Peterson O, Chance B. Bioenergetic heterogeneity of human mitochondrial myopathies: phosphorus magnetic resonance spectroscopy study. Neurology 1987;37:257-62.
12. 31P magnetic resonance, and biochemical investigation. J Neurol Sci 1985;71:105-18.
13. 31P MR spectroscopy indicating a multisystem mitochondrial defect. J Neurol Sci 1996;137:20-7.
14. Kemp GJ, Taylor DJ, Dunn JF, Frostick SP, Radda GK. Cellular energetics of dystrophic muscle. J Neurol Sci 1998;116:201-6.
15. Newman RJ, Bore PJ, Chan L, Gadian DG, Styles P, Taylor D, Radda GK. Nuclear magnetic resonance studies of forearm muscle in Duchenne dystrophy. Br Med J 1982;284:1072-4.
16. 31P NMR studies in Duchenne muscular dystrophy: age related metabolic changes. Neurology 1987;37:165-9.
17. 31P NMR: controlled trials show no effect of allopurinol or ribose. Muscle and Nerve 1985;8:760-7.
18. 31P-NMR spectroscopy of skeletal muscle in Becker dystrophy and DMD/BMD carriers. Altered rate of phosphate transport. J Neurol Sci 1992;109:188-95.
19. 31P magnetic resonance spectroscopy study. Brain 1999;122:121-30.
20. 31P magnetic resonance spectroscopy study. Brain 1997;120:1699-711.
21. Taylor DJ, Kemp GJ, Woods CG, Edwards JH, Radda GK. Skeletal muscle bioenergetics in myotonic dystrophy. J Neurol Sci 1993;116:193-200.
22. Daniel Y, Sze, Jardetzkey O. Determination of metabolite and nucleotide concentrations in proliferating lymphocytes by 1H NMR of acid extracts. Biochim Biophys Acta 1991;1054:181-97.
23. 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas, and non-involved breast tissue. NMR Biomed 1994;7:181-94.
24. 1H NMR spectrostudies of liver extracts of carbon tetrachloride treated rats. NMR Biomed 1999;12:395-401.
25. Remy C, Arus C, Ziegler A, Lai ES, Moreno A, Fur YL, Decorps M. In-vitro, ex-vivo, and in-vitro one and two-dimensional nuclear magnetic resonance spectroscopy of an intracerebral glioma in rat brain: assignment of resonances. J Neurochem 1994;62:166-79.
26. Boss EA, Moolenaar SH, Leon FA, Massuger AG, Boonstra H, Engleke UFH, Jong JGN, Wevers RA. High-resolution proton nuclear magnetic resonance spectroscopy of ovarian cyst fluid. NMR Biomed 2000;13:297-305.
27. Wevers RA, Englke U, Heerschap A. High resolution 1H NMR spectroscopy of blood plasma for metabolic studies. Clin Chem 1994;40:1245-50.
28. Venkatasubramanian PN, Arus C, Barany M. Two-dimensional proton magnetic resonance of human muscle extracts. Clin Physiol Biochem 1986;4:1-7.
29. McIntosh L, Granber KE, Briere KM, Anderson JE. Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: correlation with repair. NMR Biomed 1998;11:1-10.
30. Griffin JL, Williams HJ, Sang E, Clarke K, Rae C, Nicholson JK. Metabolic profiling of genetic disorders: a multislice 1H nuclear magnetic resonance spectroscopic and pattern recognition study into dystrophic tissue. Anal Biochem 2001;293:16-21.
31. 31P magnetic resonance spectroscopy of muscle extracts in malignant hyperthermia susceptible patients. Anesthesiology 1996;84:1077-82.
32. Sharma U, Chaudhury K, Jagannathan NR, Guha SK. A proton NMR study of the effect of a new intravasal injectable male contraceptive RISUG on seminal plasma metabolites. Reproduction 2001;122:431-6.
33. 31P NMR spectroscopy study. J Neurol Sci 1993;119:65-73.
34. Dunn JF, Frostic S, Brown G, Radda GK. Energy status of cells lacking dystrophin: an in-vivo/in-vitro study of mdx mouse skeletal muscle. Biochim Biophys Acta 1991;1096:115-20.
35. Nishio H, Wada H, Matsuo T, Harikawa H, Takahashi K, Nakajima T. Matsuo M, Nakamuro H. Glucose, free fatty acid, and ketone body metabolism in Duchenne muscular dystrophy. Brain Dev 1990;12:390-402.
36. Drefus JC, Schapira G, Schapira F, Demos J. Activites enzymatiques du muscle humain: recherches sur la bichimie comparee de l'homme normal et myopathique et du rat. Clin Chim Acta 1956;1:434-49.
37. Ellis DA. Intermediary metabolism of muscle in Duchenne muscular dystrophy. Br Med Bull 1980;36:165-71.
38. Ibrahim GA, Zweber BA, Essam BA, Awad A. Muscle and serum enzymes and isoenzymes in muscular dystrophies. Arch Phys Med Rehabil 1981;62:265-9.
39. 2+-ATPase and acyclphosphatase activities in muscle biopsies from patients with Duchenne muscular dystrophy. Clin Chim Acta 1986;158:245-51.
40. Johnson E, Young MK, Stacy YP, Beatty CH. Erythrocyte glucose metabolism in Duchenne muscular dystrophy. Clin Chim Acta 1979;98:77-85.
41. Schapira F. Isozymes and differentiation. Biomedicine 1978;28:1-5.
42. Brody IA. Significance of lactate dehydrogenase isoenzymes in abnormal human skeletal muscle. Neurology (Minneap) 1964;14:1091-100.
43. Lacner AL. The dehydrogenase isoenzymes. Proc Ass Clin Biochem 1964;3:120-9.
44. Lauryseens MG, Lauryssens MJ, Zondag HA. Electrophoretic distribution pattern of lactate dehydrogenase in mouse and human muscular dystrophy. Clin Chim Acta 1964;9:276-84.
45. Fritz IB, Davis DG, Holtrop RH, Dundee H. Fatty acid oxidation by skeletal muscle during rest and activity. Am J Physiol 1958;194:379-86.
46. Jagannathan NR, Wadhwa S. In-vivo proton magnetic resonance spectroscopy (MRS) study of post polio residual paralysis (PPRP) patients. Magn Reson Imag 2002;20:113-7.
47. Green DE. Fatty acid oxidation in soluble systems of animal tissues. Biol Rev 1954;29:330-66.
48. Lynen F, Ochoa S. Enzymes of fatty acid metabolism. Biochim Biophys Acta 1953;12:299-314.
49. Flavin M, Ochoa S. Metabolism of propionic acid in animal tissues I. Enzymatic conversion of propionate to succinate. J Biol Chem 1957;229:965-79.
50. Nurjhan N, Bucci A, Perriello G. Glutamine: a major gluconeogenic precursor, and vehicle for interorgan carbon transport in man. J Clin Invest 1995;95:272-7.
51. Hankard R, Haymond M, Darmaun D. Role of glutamine as a glucose precursor in fasting humans. Diabetes 1997;46:1535-41.
52. Windmueller H, Spaeth A. Respiratory fuels and nitrogen metabolism in vivo in small intestine of fed rats. Quantitative importance of glutamine, glutamate and aspartate. J Biol Chem 1980;25:69-76.
53. Newsholme E, Crabtree B, Ardawi M. Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. Q J Exp Physiol 1985;70:473-89.
54. Hankard R, Haymond M, Darmaun D. Effect of glutamine on leucine metabolism in humans. Am J Physiol 1996;271:E748-54.
55. Darmaun D, Welch S, Rini A, Sager BK, Altomare A, Haymond MW. Phenylbutyrate-induced glutamine depletion in humans: effect leucine metabolism. Am J Physiol 1998;274:E801-7.
56. Hankard RG, Hammond MW, Darmaun D. Oral glutamine slows down whole body protein breakdown in Duchenne muscular dystrophy. Pediatric Res 1998;43:222-6.
57. Hankard R, Mauras N, Hammond D, Haymond M, Darmaun D. Is glutamine a conditionally essential amino acid in Duchenne muscular dystrophy. Clin Nutrition 1999;18:365-9.
58. Burt CT, Ribolow HJ. A hypothesis: noncyclic phosphodiesters may play a role in membrane control. Biochem Med 1984;31:21-40.
59. Weltzein HU. Cytolytic and membrane perturbing properties of lysophosphatidylcholine. Biochim Biophys Acta 1979;559:259-87.
60. Lucy JA. Is there a membrane defect in muscle and other cells? Br Med Bull 1980;36:187-92.
61. Farias RN, Bloj B, Moreo RD, Sinerz F, Trucco RE. Regulation of allosteric membrane bound enzymes through changes in membrane lipid composition. Biochim Biophys Acta 1975;415:215-31.
62. Nagasawa T, Yonekura T, Nishizawa N, Kitts DD. In vitro and in vivo inhibition of muscle lipid and protein oxidation by carnosine. Mol Cell Biochem 2001;225:29-34.
63. Sugden PH, Fuller SJ. Regulation of protein turnover in skeletal and cardiac muscle. Biochem J 1991;273:21-37.